ClinicalTrials.gov
public full text
Public Domain
A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies
The main objectives of this study are to evaluate the side effects of MKC-1 and to determine a safe dose of MKC-1 for future studies in patients with hematological malignancies
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase 2 Study of Oral MKC-1 in Patients With Ovarian or Endometrial Cancer#980083
- Phase 1 Study of MKC-1 in Patients With Advanced Cancer#904745
- A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)#1112611
- NUC-1031 in Patients With Advanced Solid Tumours#900308
- TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)#836652
Record · ID 981554
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive